BioStock: Aptahem recruits to key positions before clinical studies

Aptahem has recently recruited to fill three key positions ahead of the phase I studies planned with sepsis candidate Apta-1. Karin Aschan is the company’s new Regulatory Affairs Director, while Maria Ekblad takes the position as new Chief Operating Officer. Thomas Rupp expands his involvement in Aptahem and assumes the role of CMC Director in the company. BioStock contacted CEO Mikael Lindstam for a brief comment on the timing of the recruitments, and what the agenda for 2022 looks like.

Read the full interview with Mikael Lindstam at biostock.se:

https://www.biostock.se/en/2022/02/aptahem-recruits-to-key-positions-before-clinical-studies/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/